Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiviral oral liquid for ordinary hand-foot-mouth disease in children
ChiCTR-TRC-10000933Phase 4Completed
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Mar 2010
- Countries
- 1
01
Overview
Phase 4, randomised trial of Kangbingdu oral liquid in hand, foot, and mouth disease (HFMD) (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Pyretolysis time. Started Mar 2010; status: completed.
02
Drugs
Kangbingdu oral liquid
03
Conditions
hand, foot, and mouth disease (HFMD)
Beyond the preview
Go deeper on ChiCTR-TRC-10000933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000933.